Robert Wasserman
Stock Analyst at Benchmark Co.
(4.34)
# 1,329
Out of 4,996 analysts
232
Total ratings
46.8%
Success rate
11.7%
Average return
Main Sectors:
Stocks Rated by Robert Wasserman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TLV: KMDA Kamada Ltd. | Reiterated: Buy | ILA 4,522 | ILA 2,668 | +69.49% | 6 | Sep 18, 2026 | |
| BLFS BioLife Solutions | Downgraded: Hold | n/a | $37.74 | - | 11 | Aug 10, 2026 | |
| LGND Ligand Pharmaceuticals | Reiterated: Buy | $220 → $335 | $298.41 | +12.26% | 20 | Jul 16, 2026 | |
| RGEN Repligen | Upgraded: Buy | $185 | $184.53 | +0.25% | 11 | Jul 7, 2026 | |
| PRLB Proto Labs | Reiterated: Buy | $91 | $89.13 | +2.10% | 16 | Jul 6, 2026 | |
| TECH Bio-Techne | Downgraded: Hold | n/a | $72.52 | - | 18 | Jun 30, 2026 | |
| ITGR Integer Holdings | Upgraded: Buy | $140 → $95 | $126.32 | -24.79% | 18 | Feb 20, 2026 | |
| HALO Halozyme Therapeutics | Reiterated: Buy | $90 | $112.44 | -19.96% | 22 | Feb 19, 2026 | |
| CDXS Codexis | Reiterated: Hold | n/a | $1.38 | - | 16 | Nov 14, 2025 | |
| OABI OmniAb | Reiterated: Buy | $6 → $4 | $4.79 | -16.49% | 11 | Nov 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $4.06 | +824.78% | 7 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $12.31 | n/a | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $4.29 | n/a | 8 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $6.67 | n/a | 20 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $3 | $1.39 | n/a | 8 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $4 | $3.55 | n/a | 1 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $665.30 | n/a | 7 | Oct 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $221.56 | n/a | 5 | Oct 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.02 | n/a | 4 | Sep 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 → $80 | $1.89 | n/a | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $2.34 | n/a | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.68 | n/a | 3 | Jan 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.60 | n/a | 1 | Jan 9, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $4.2 | $6.50 | n/a | 1 | Oct 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $46 | $0.849 | n/a | 1 | Aug 28, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $2.4 | $2.12 | n/a | 2 | Jan 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.25 | $0.9025 | n/a | 1 | Nov 7, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $8.40 | n/a | 1 | Mar 12, 2013 |
Kamada Ltd.
Sep 18, 2026
Reiterated: Buy
Price Target: ILA 4,522
Current: ILA 2,668
Upside: +69.49%
BioLife Solutions
Aug 10, 2026
Downgraded: Hold
Price Target: n/a
Current: $37.74
Upside: -
Ligand Pharmaceuticals
Jul 16, 2026
Reiterated: Buy
Price Target: $220 → $335
Current: $298.41
Upside: +12.26%
Repligen
Jul 7, 2026
Upgraded: Buy
Price Target: $185
Current: $184.53
Upside: +0.25%
Proto Labs
Jul 6, 2026
Reiterated: Buy
Price Target: $91
Current: $89.13
Upside: +2.10%
Bio-Techne
Jun 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $72.52
Upside: -
Integer Holdings
Feb 20, 2026
Upgraded: Buy
Price Target: $140 → $95
Current: $126.32
Upside: -24.79%
Halozyme Therapeutics
Feb 19, 2026
Reiterated: Buy
Price Target: $90
Current: $112.44
Upside: -19.96%
Codexis
Nov 14, 2025
Reiterated: Hold
Price Target: n/a
Current: $1.38
Upside: -
OmniAb
Nov 6, 2025
Reiterated: Buy
Price Target: $6 → $4
Current: $4.79
Upside: -16.49%
Oct 31, 2025
Reiterated: Buy
Price Target: $38
Current: $4.06
Upside: +824.78%
Aug 13, 2025
Reiterated: Hold
Price Target: n/a
Current: $12.31
Upside: n/a
Aug 12, 2025
Reiterated: Buy
Price Target: $5
Current: $4.29
Upside: n/a
Aug 8, 2025
Reiterated: Buy
Price Target: $12
Current: $6.67
Upside: n/a
Jul 31, 2025
Reiterated: Buy
Price Target: $3
Current: $1.39
Upside: n/a
Feb 3, 2025
Downgraded: Hold
Price Target: $4
Current: $3.55
Upside: n/a
Oct 26, 2023
Reiterated: Hold
Price Target: n/a
Current: $665.30
Upside: n/a
Oct 25, 2023
Reiterated: Hold
Price Target: n/a
Current: $221.56
Upside: n/a
Sep 15, 2023
Reiterated: Hold
Price Target: n/a
Current: $5.02
Upside: n/a
Apr 4, 2023
Reiterated: Buy
Price Target: $9 → $80
Current: $1.89
Upside: n/a
Feb 24, 2021
Reiterated: Buy
Price Target: $9
Current: $2.34
Upside: n/a
Jan 24, 2020
Rated: Hold
Price Target: n/a
Current: $1.68
Upside: n/a
Jan 9, 2019
Initiated Coverage: Buy
Price Target: $11
Current: $0.60
Upside: n/a
Oct 17, 2018
Initiated Coverage: Buy
Price Target: $4.2
Current: $6.50
Upside: n/a
Aug 28, 2018
Initiated Coverage: Buy
Price Target: $46
Current: $0.849
Upside: n/a
Jan 29, 2018
Initiated Coverage: Buy
Price Target: $2.4
Current: $2.12
Upside: n/a
Nov 7, 2013
Initiated Coverage: Buy
Price Target: $5.25
Current: $0.9025
Upside: n/a
Mar 12, 2013
Reiterated: Buy
Price Target: $6
Current: $8.40
Upside: n/a